Clinical Utility of Homologous Recombination Deficiency (HRD) Profiling in Ovarian Cancer: An Indian Experience

被引:0
|
作者
Bahadur, U. [1 ]
Ravichandran, A. [1 ]
Basu, S. [1 ]
Nayanala, S. [1 ]
Vishwanath, D. [1 ]
Muniyappa, N. [1 ]
Neelagandan, B. G. K. [1 ]
Ramkumar, A. N. J. A. [1 ]
Sajjad, S. [1 ]
Nair, R. H. J. J. [1 ]
Krishnan, G. [1 ]
Ramanathan, V. G. R. A. [1 ]
Chatterjee, A. [1 ]
Sridharan, S. [1 ]
Phalke, S. [1 ]
Veeramachaneni, V. [1 ]
机构
[1] Strand Life Sci, Bangalore, Karnataka, India
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
ST051
引用
收藏
页码:S106 / S106
页数:1
相关论文
共 50 条
  • [31] Characteristics of homologous recombination deficiency (HRD) in paired primary and recurrent high-grade serous ovarian cancer (HGSOC).
    Patel, Jai Narendra
    Sehouli, Jahid
    Timms, Kirsten
    Solimeno, Cara
    Reid, Julia E.
    Lanchbury, Jerry S.
    Braicu, Ioana
    Darb-Esfahani, Silvia
    Ganapathi, Mahrukh
    Ganapathi, Ram N.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Role of BRCA1 promotor methylation in homologous recombination deficiency (HRD) in high-grade ovarian cancer
    Fiegl, H.
    Reimer, D.
    Schnaiter, S.
    Leitner, K.
    Wimmer, K.
    Schamschula, E.
    Steger, K.
    Marth, C.
    Zeimet, A. G.
    ANNALS OF ONCOLOGY, 2023, 34 : S527 - S527
  • [33] An optimized homologous recombination deficiency (HRD) algorithm ASGAD for predicting PARP inhibitor response in ovarian cancer patient.
    Jiao, Yang
    Chen, Dong Ju
    Liu, Bo
    Meng, Pei
    Sun, Lei
    Cai, Yu Hang
    Shi, Tai Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] In-House Testing for Homologous Recombination Deficiency (HRD) in Mexican Patients with High-Grade Serous Ovarian Cancer
    Abreu-Gonzalez, Melania
    Santillan-Martinez, Rosalia
    Garcia-Ortiz, Ramiro
    Alvarez Ordorica, Oliver
    Martinez-Cannon, Bertha A.
    Hernandez Luis, Gisela
    Tellez Bernal, Eduardo
    Cortes Esteban, Patricia
    Blanco Vazquez, Yazmin C.
    Lopez Rosas, Gilberto
    Gomez Garcia, Eva M.
    Sanchez Llamas, Benito
    Rojas Toledo, Emma X.
    Martinez Gutierrez, Selena
    Azotla Vilchis, Coztli O.
    Rodriguez Munoz, Yolanda F.
    Munoz, Alexia
    Montes-Servin, Edgar
    Mendoza-Maldonado, Lucero
    Vaisman, Carolina E.
    Juarez Rodriguez, Rocio
    Flores Palacios, Jose A.
    Lara Torres, Cesar O.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (06): : S53 - S54
  • [35] Characteristics of homologous recombination deficiency (HRD) in paired primary and recurrent high-grade serous ovarian cancer (HGSOC)
    Patel, J.
    Sehouli, J.
    Timms, K.
    Solimeno, C.
    Reid, J.
    Lanchbury, J.
    Braicu, I.
    Darb-Esfahani, S.
    Ganapathi, M.
    Ganapathi, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [36] Development of model for identifying homologous recombination deficiency (HRD) status of ovarian cancer with deep learning on whole slide images
    Zhang, Ke
    Qiu, Youhui
    Feng, Songwei
    Yin, Han
    Liu, Qi
    Zhu, Yuxin
    Cui, Haoyu
    Wei, Xiaoying
    Wang, Guoqing
    Wang, Xiangxue
    Shen, Yang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [37] Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer
    Fountzilas, Elena
    Papadopoulou, Kyriaki
    Chatzikonstantinou, Thomas
    Karakatsoulis, Georgios
    Constantoulakis, Pantelis
    Tsantikidi, Aikaterini
    Tsaousis, Georgios
    Karageorgopoulou, Sofia
    Koumarianou, Anna
    Mauri, Davide
    Ntavatzikos, Anastasios
    Saridaki, Zacharenia
    Petrakis, Georgios
    Fostira, Florentia
    Fountzilas, George
    Liontos, Michalis
    CANCERS, 2023, 15 (23)
  • [38] Homologous-recombination deficiency (HRD) in gastroesophageal adenocarcinoma (GEA): Clinical and molecular features
    Acosta Eyzaguirre, D.
    Castillo, G.
    Aguilar Izquierdo, S.
    Cruellas Lapena, M.
    Herencia Ropero, A.
    Landolfi, S.
    Palma, H.
    Tian, T.
    Vivancos, A.
    Serra Elizalde, V.
    Macarulla Mercade, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S189 - S189
  • [39] Origins, signatures, and clinical impacts of homologous recombination deficiency (HRD) in Asian breast cancers
    Ju, Young Seok
    Kim, Ryul
    Park, Yeon Hee
    Ju, Young Seok
    CANCER SCIENCE, 2025, 116 : 629 - 629
  • [40] Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types
    Takamatsu, Shiro
    Brown, J. B.
    Yamaguchi, Ken
    Hamanishi, Junzo
    Yamanoi, Koji
    Takaya, Hisamitsu
    Kaneyasu, Tomoko
    Mori, Seiichi
    Mandai, Masaki
    Matsumura, Noriomi
    JCO PRECISION ONCOLOGY, 2022, 6